In breast invasive carcinoma, among the CXCR2 ligands, only CXCL2 inhibits proliferation, and this chemokine was the only one among those analyzed that was negatively correlated with the count of macrophages. This evidence concerns the gene CXCR2 and invasive breast carcinoma.